SE7601841L - Sett att framstella en bakteriekomponent av pseudomonas aeruginosa - Google Patents

Sett att framstella en bakteriekomponent av pseudomonas aeruginosa

Info

Publication number
SE7601841L
SE7601841L SE7601841A SE7601841A SE7601841L SE 7601841 L SE7601841 L SE 7601841L SE 7601841 A SE7601841 A SE 7601841A SE 7601841 A SE7601841 A SE 7601841A SE 7601841 L SE7601841 L SE 7601841L
Authority
SE
Sweden
Prior art keywords
manufacturing
pseudomonas aeruginosa
bacteria component
bacteria
component
Prior art date
Application number
SE7601841A
Other languages
English (en)
Other versions
SE434701B (sv
Inventor
Y Homma
C Abe
K Tanamoto
K Kuretani
A Hoshi
Original Assignee
Univ Tokyo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tokyo filed Critical Univ Tokyo
Publication of SE7601841L publication Critical patent/SE7601841L/sv
Publication of SE434701B publication Critical patent/SE434701B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/874—Pseudomonas
    • Y10S435/875—Pseudomonas aeruginosa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
SE7601841A 1975-05-14 1976-02-18 Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa SE434701B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50055979A JPS51133489A (en) 1975-05-14 1975-05-14 Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities

Publications (2)

Publication Number Publication Date
SE7601841L true SE7601841L (sv) 1976-11-15
SE434701B SE434701B (sv) 1984-08-13

Family

ID=13014183

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7601841A SE434701B (sv) 1975-05-14 1976-02-18 Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa

Country Status (7)

Country Link
US (1) US4079126A (sv)
JP (1) JPS51133489A (sv)
CA (1) CA1060797A (sv)
DE (1) DE2610504C2 (sv)
FR (1) FR2311093A1 (sv)
GB (1) GB1537509A (sv)
SE (1) SE434701B (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1085293A (en) * 1976-02-05 1980-09-09 Yuzuru Homma Toxoids derived from protease and elastase of pseudomonas aeruginosa and production thereof
JPS5296729A (en) * 1976-02-05 1977-08-13 Shionogi & Co Ltd Mixed vaccin for cyanomycosis
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
CA1256370A (en) * 1984-02-24 1989-06-27 Yuzuru Homma Toxoids of elastase of pseudomonas aeruginosa origin
AT384032B (de) * 1985-01-14 1987-09-25 Immuno Ag Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
US5179001A (en) * 1985-09-27 1993-01-12 The Regents Of The University Of California Detection and monitoring of chronic and gram-negative infection
AT391080B (de) * 1986-06-24 1990-08-10 Immuno Ag Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
US5237053A (en) * 1986-06-24 1993-08-17 Immuno Aktiengesellschaft Preparation active against Pseudomonas aeruginosa infections and methods of producing them
FR2613380B1 (fr) * 1987-04-06 1989-11-17 Pasteur Institut Nouvelle substance adjuvante de certains antimitotiques chimiques, procede d'obtention de cette substance a partir de cultures de vibrio cholerae, agents therapeutiques contenant ladite substance
DE69032484D1 (de) * 1989-10-27 1998-08-20 Arch Dev Corp Zusammensetzungen und deren verwendung zur förderung der immunopotentiation
US6406696B1 (en) 1989-10-27 2002-06-18 Tolerance Therapeutics, Inc. Methods of stimulating the immune system with anti-CD3 antibodies
US6491916B1 (en) 1994-06-01 2002-12-10 Tolerance Therapeutics, Inc. Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
US20030108548A1 (en) * 1993-06-01 2003-06-12 Bluestone Jeffrey A. Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
US8663634B2 (en) * 2005-07-11 2014-03-04 Macrogenics, Inc. Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
JP2009544761A (ja) * 2006-06-14 2009-12-17 マクロジェニクス，インコーポレーテッド 低毒性免疫抑制モノクローナル抗体を用いて自己免疫疾患を治療する方法
CA2673470A1 (en) * 2006-12-21 2008-07-03 Macrogenics, Inc. Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity
KR102198749B1 (ko) * 2011-03-02 2021-01-06 제롬 쉔타그 단독으로 또는 c형 간염 바이러스 감염과 결합되는 간 지방증의 치료를 위한 조성물, 방법 및 진단
CN109401992B (zh) * 2017-08-18 2021-07-23 黑龙江省科学院微生物研究所 一株高产内毒素蛋白的铜绿假单胞菌及其应用
MX2023013851A (es) 2021-05-24 2023-12-08 Provention Bio Inc Metodos para el tratamiento de diabetes tipo 1.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS496096B1 (sv) * 1970-09-30 1974-02-12
GB1365950A (en) * 1970-10-20 1974-09-04 Eisai Co Ltd Pharmaceutical composition comprising a cell wall protein compo nent of pseudomonas aeruginosa
FR2184531B1 (sv) * 1972-05-19 1975-10-17 Anvar

Also Published As

Publication number Publication date
SE434701B (sv) 1984-08-13
DE2610504A1 (de) 1976-11-25
DE2610504C2 (de) 1985-07-11
GB1537509A (en) 1978-12-29
FR2311093A1 (fr) 1976-12-10
JPS51133489A (en) 1976-11-19
JPS6123167B2 (sv) 1986-06-04
FR2311093B1 (sv) 1979-06-29
US4079126A (en) 1978-03-14
CA1060797A (en) 1979-08-21

Similar Documents

Publication Publication Date Title
SE7609968L (sv) Sett att tillverka patronhylsor
SE426212B (sv) Sett for framstellning av mikrokapslar
SE7611839L (sv) Sett att framstella en glasogonlins med progressivt varierande ljusbrytningsformaga
SE7504914L (sv) Sett att framstella formkroppar av polyolefiner.
SE7711222L (sv) Sett att framstella luggyteforsedda produkter
BR7604255A (pt) Roda dentada
GB1538933A (en) Method of preventing mink infection by pseudomonas aeruginosa
SE385469B (sv) Sett att framstella letta kornformiga material och anordning for genomforandet av settet
SE426595B (sv) Forfarande for framstellning av cellulosaetrar
ATA58276A (de) Zahnrad
SE7609442L (sv) Sett att framstella en blandning, exempelvis anvendbar for tillverkning av byggnadsmaterial, jemte anordning for settets genomforande
SE409259B (sv) Sett att framstella en halvledaranordning av aŸiŸiŸi bŸv - halvledarmaterial
SE398872B (sv) Sett att framstella en glasdel avsedd for elektroniska apparater
SE7607239L (sv) Sett att framstella beta-acylpyrroler
SE7710514L (sv) Sett att framstella kiselhaltigt gjutjern
SE427196B (sv) Sett vid tillverkning av cellulosamassa
SE393620B (sv) Sett att framstella perlor av karbamid-formaldehydharts
SE7613228L (sv) Sett att tillverka foremal genom sammansettning av vedartade smadelar samt anordning for utovande av settet
SE7613545L (sv) Sett att framstella difluormetyl-1,2,2-triflnoretyleter
JPS5222760A (en) Method of manufacturing film capacitor
SE416598B (sv) Forfarande for framstellning av en transistor
SE7705841L (sv) Sett att framstella brandhemmande skiljeveggselement
SE7613122L (sv) Sett att framstella 4-klor-2-butynyl-m-klorkarbanilat
SE7605131L (sv) Sett att framstella 3-acyloximetyl-cefemforeningar
SE7908066L (sv) Sett att framstella formkroppar av plast